Popat, R., Uttervall, K., Kortüm, K., Magen, H., Hansson, M., Shragai, T., Terpos, E., Hansen, C. T., Manier, S., Gregersen, H., Ottestad, Ø.M., Touzeau, C., Hatjiharissi, E., Farmer, S., Katodritou, E., Spanoudakis, E., Vase, M., Liberatore, C., Papathanasiou, M., Angelopoulou, M., Clavero, E., Kittus, R., Smirnov, P., Hu, P., Santra, D., Albrecht, C., Rubio-Azpeitia, E. and Perrot, A. (2026) “P41 | FIRST RESULTS OF REALiTEC-2: SECOND COHORT OF REALiTEC, AN INTERNATIONAL OBSERVATIONAL RETROSPECTIVE STUDY OF TECLISTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN ROUTINE CLINICAL PRACTICE”, Haematologica. Pavia, Italy, 111(s2). doi: 10.3324/haematol.2026.s2.14038.